Multiple Sclerosis, Relapsing-Remitting
227
21
33
138
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
44 trials with published results (19%)
Research Maturity
138 completed trials (61% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
9.7%
22 terminated out of 227 trials
86.3%
-0.3% vs benchmark
26%
59 trials in Phase 3/4
32%
44 of 138 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 138 completed trials
Clinical Trials (227)
Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
Fatigue Alleviation Through Neuromodulating Therapy in Multiple Sclerosis
Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis: A Trans-regional Digital Health Effort Unlocking the Potential of Artificial Intelligence and Data Science in Health Care
Dietary Approaches to Treat Multiple Sclerosis-Related Fatigue Study
Efficacy of Diet on Quality of Life in Multiple Sclerosis
Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS
Examining Effects of Ocrevus on Cognitive Fatigue Using fMRI
Examining Effects of Tysabri on Cognitive Fatigue Using fMRI
A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMS
Cognitive Disability and Quality of Life of Patients Suffering From Multiple Sclerosis and Treatment With Immunosuppressant
Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple Sclerosis
Effects of Chiropractic Care on Cytokine Levels in Multiple Sclerosis
Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
Effects of Task-oriented Training on Functional Mobility and Fatigue in Patients With Multiple Sclerosis
Peer Support Impact on Therapeutic Adherence in Patients With Multiple Sclerosis
B Cell Tailored Ocrelizumab Versus Standard Ocrelizumab in Relapsing Remitting Multiple Sclerosis